tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TCRX Stock Latest News

TScan Therapeutics Updates Corporate Milestones and Strategies
Company AnnouncementsTScan Therapeutics Updates Corporate Milestones and Strategies
19d ago
8K
TCRX
TScan Therapeutics: Promising Developments and Strategic Advancements Drive Buy Rating
PremiumRatings
TScan Therapeutics: Promising Developments and Strategic Advancements Drive Buy Rating
1M ago
TCRX
Strategic Advancements and Promising Trial Data Propel TScan Therapeutics to ‘Buy’ Rating
PremiumRatings
Strategic Advancements and Promising Trial Data Propel TScan Therapeutics to ‘Buy’ Rating
1M ago
TCRX
TScan Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
TScan Therapeutics Reports Q2 2025 Financial Results
2M ago
TCRX
TScan Therapeutics reports Q2 EPS (28c), consensus (32c)
PremiumThe Fly
TScan Therapeutics reports Q2 EPS (28c), consensus (32c)
2M ago
TCRX
TScan Therapeutics expects cash to fund operations into Q1 of 2027
PremiumThe FlyTScan Therapeutics expects cash to fund operations into Q1 of 2027
2M ago
TCRX
TCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
TCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
TCRX
TScan Therapeutics Elects New Directors at Annual Meeting
Premium
Company Announcements
TScan Therapeutics Elects New Directors at Annual Meeting
3M ago
8K
TCRX
TScan Therapeutics management to meet virtually with BTIG
PremiumThe Fly
TScan Therapeutics management to meet virtually with BTIG
5M ago
TCRX
TScan Therapeutics price target lowered to $10 from $15 at H.C. Wainwright
PremiumThe Fly
TScan Therapeutics price target lowered to $10 from $15 at H.C. Wainwright
5M ago
TCRX
TScan Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
TScan Therapeutics Reports Q1 2025 Financial Results
5M ago
TCRX
Positive Outlook for TScan Therapeutics: Buy Rating Backed by Strong Financials and Promising Clinical Developments
PremiumRatings
Positive Outlook for TScan Therapeutics: Buy Rating Backed by Strong Financials and Promising Clinical Developments
5M ago
TCRX
TScan Therapeutics reports Q1 EPS (26c), consensus (28c)
PremiumThe FlyTScan Therapeutics reports Q1 EPS (26c), consensus (28c)
5M ago
TCRX
TScan Therapeutics appoints Camiolo as SVP, Market Access
Premium
The Fly
TScan Therapeutics appoints Camiolo as SVP, Market Access
6M ago
TCRX
TScan Therapeutics assumed with an Overweight at Morgan Stanley
Premium
The Fly
TScan Therapeutics assumed with an Overweight at Morgan Stanley
7M ago
TCRX
TScan Therapeutics: Promising Advances in TCR-Engineered Cancer Therapies Justify Buy Rating
PremiumRatings
TScan Therapeutics: Promising Advances in TCR-Engineered Cancer Therapies Justify Buy Rating
7M ago
TCRX
Positive Buy Rating for TScan Therapeutics Driven by Promising Clinical Data and Strong Financial Position
PremiumRatings
Positive Buy Rating for TScan Therapeutics Driven by Promising Clinical Data and Strong Financial Position
7M ago
TCRX
TScan Therapeutics price target lowered to $3 from $14 at Barclays
PremiumThe Fly
TScan Therapeutics price target lowered to $3 from $14 at Barclays
7M ago
TCRX
Positive Outlook for TScan Therapeutics: Buy Rating Affirmed Due to Promising TCR-T Cell Therapy Progress and Solid Financial Position
PremiumRatings
Positive Outlook for TScan Therapeutics: Buy Rating Affirmed Due to Promising TCR-T Cell Therapy Progress and Solid Financial Position
7M ago
TCRX
Promising Clinical Differentiation and Strategic Advancements Drive Buy Rating for TScan Therapeutics
PremiumRatingsPromising Clinical Differentiation and Strategic Advancements Drive Buy Rating for TScan Therapeutics
7M ago
TCRX
Promising Progress and Strategic Expansion Position TScan Therapeutics for Success
Premium
Ratings
Promising Progress and Strategic Expansion Position TScan Therapeutics for Success
7M ago
TCRX
TScan Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
TScan Therapeutics Reports 2024 Financial Results and Progress
7M ago
TCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >